SynthesisFrontiers in pharmacology2026
Efficacy and safety of lecanemab monoclonal antibody in the treatment of mild to moderate Alzheimer's disease: a systematic review and meta-analysis.
Shang-Ying Li et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.